• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

绝经后激素替代疗法相关的乳腺X线变化:一项纵向研究。

Mammographic changes associated with postmenopausal hormone replacement therapy: a longitudinal study.

作者信息

Stomper P C, Van Voorhis B J, Ravnikar V A, Meyer J E

机构信息

Department of Radiology, Roswell Park Memorial Institute, School of Medicine and Biomedical Science, SUNY, Buffalo 14263.

出版信息

Radiology. 1990 Feb;174(2):487-90. doi: 10.1148/radiology.174.2.2136958.

DOI:10.1148/radiology.174.2.2136958
PMID:2136958
Abstract

A retrospective study of radiologic findings from 50 postmenopausal women who underwent hormone replacement therapy was performed to determine the frequency and distribution of changes in the screen-film mammographic appearance of breast tissue between pretreatment and posttreatment mammography. Twelve (24%) of the women developed increased parenchymal density during a median follow-up of 18 months (range, 6-39 months). Mammographic changes included diffuse increase in density in seven (14%) of the women; increased multifocal, asymmetric densities in two (4%); and cyst formation in three (6%). A greater percentage of women who received estrogen-progesterone replacement (26%, 10 of 38) demonstrated changes than those who received estrogen alone (17%, two of 12), but the difference was not statistically significant. The authors conclude that benign increases in mammographic density associated with postmenopausal hormone replacement therapy are not uncommon, and they suggest that the serial changes observed in some women may diminish the sensitivity of mammography for the earlier detection of breast cancer.

摘要

对50名接受激素替代疗法的绝经后女性的放射学检查结果进行了一项回顾性研究,以确定治疗前和治疗后乳房X线摄影中乳腺组织影像表现变化的频率和分布。在中位随访18个月(范围6 - 39个月)期间,12名(24%)女性出现实质密度增加。乳房X线摄影变化包括7名(14%)女性密度弥漫性增加;2名(4%)女性多灶性、不对称密度增加;3名(6%)女性出现囊肿形成。接受雌激素 - 孕激素替代治疗的女性(26%,38名中的10名)出现变化的比例高于仅接受雌激素治疗的女性(17%,12名中的2名),但差异无统计学意义。作者得出结论,绝经后激素替代疗法相关的乳房X线摄影密度良性增加并不罕见,他们还指出,在一些女性中观察到的系列变化可能会降低乳房X线摄影对早期乳腺癌检测的敏感性。

相似文献

1
Mammographic changes associated with postmenopausal hormone replacement therapy: a longitudinal study.绝经后激素替代疗法相关的乳腺X线变化:一项纵向研究。
Radiology. 1990 Feb;174(2):487-90. doi: 10.1148/radiology.174.2.2136958.
2
[A mammographic evaluation of the morphostructural variations of the breast during hormone-replacement therapy in the postmenopause].[绝经后激素替代治疗期间乳腺形态结构变化的乳腺X线摄影评估]
Radiol Med. 1998 Jun;95(6):573-6.
3
Effect of long-term continuous combined hormone replacement therapy with estradiol valerate and either dienogest or norethisterone acetate on mammographic density in postmenopausal women.戊酸雌二醇与地诺孕素或醋酸炔诺酮长期连续联合激素替代疗法对绝经后女性乳腺X线密度的影响。
Medscape Womens Health. 2002 Jul-Aug;7(4):1.
4
Mammographic density changes during different postmenopausal hormone replacement therapies.不同绝经后激素替代疗法期间的乳房X线密度变化。
Fertil Steril. 2001 Sep;76(3):445-50. doi: 10.1016/s0015-0282(01)01935-5.
5
Estrogen-plus-progestin use and mammographic density in postmenopausal women: Women's Health Initiative randomized trial.绝经后女性中雌激素加孕激素的使用与乳腺X线密度:妇女健康倡议随机试验
J Natl Cancer Inst. 2005 Sep 21;97(18):1366-76. doi: 10.1093/jnci/dji279.
6
Post-treatment change in serum estrone predicts mammographic percent density changes in women who received combination estrogen and progestin in the Postmenopausal Estrogen/Progestin Interventions (PEPI) Trial.在绝经后雌激素/孕激素干预(PEPI)试验中,接受雌激素和孕激素联合治疗的女性,血清雌酮的治疗后变化可预测乳房X线密度百分比的变化。
J Clin Oncol. 2004 Jul 15;22(14):2842-8. doi: 10.1200/JCO.2004.03.120.
7
Hormonal replacement therapy: mammographic manifestations.
Radiology. 1990 Jan;174(1):199-201. doi: 10.1148/radiology.174.1.2152982.
8
Influence of different HRT regimens on mammographic density.不同激素替代疗法方案对乳房X线密度的影响。
Maturitas. 2005 Feb 14;50(2):105-10. doi: 10.1016/j.maturitas.2004.04.008.
9
Effects of hormone replacement therapy regimens on mammographic breast density: the role of progestins.激素替代疗法方案对乳腺钼靶密度的影响:孕激素的作用
J Obstet Gynaecol Res. 2006 Jun;32(3):305-8. doi: 10.1111/j.1447-0756.2006.00402.x.
10
[Effects of hormonal replacement therapy on breast density in postmenopausal women].[激素替代疗法对绝经后女性乳腺密度的影响]
Minerva Ginecol. 2004 Apr;56(2):125-30.

引用本文的文献

1
Menopausal hormone therapy and breast cancer risk: a population-based cohort study of 1.3 million women in Norway.绝经激素治疗与乳腺癌风险:挪威 130 万女性的基于人群的队列研究。
Br J Cancer. 2024 Jul;131(1):126-137. doi: 10.1038/s41416-024-02590-1. Epub 2024 May 13.
2
The epidemiologic factors associated with breast density: A review.与乳腺密度相关的流行病学因素:综述
J Res Med Sci. 2022 Jul 29;27:53. doi: 10.4103/jrms.jrms_962_21. eCollection 2022.
3
Mammographic breast density and its association with urinary estrogens and the fecal microbiota in postmenopausal women.
绝经后妇女的乳腺密度及其与尿雌激素和粪便微生物群的关系。
PLoS One. 2019 May 8;14(5):e0216114. doi: 10.1371/journal.pone.0216114. eCollection 2019.
4
Mammographic density changes following discontinuation of tamoxifen in premenopausal women with oestrogen receptor-positive breast cancer.绝经前雌激素受体阳性乳腺癌妇女停用他莫昔芬后乳腺密度的变化。
Eur Radiol. 2018 Aug;28(8):3176-3184. doi: 10.1007/s00330-017-5293-y. Epub 2018 Apr 6.
5
MRI background parenchymal enhancement, breast density and serum hormones in postmenopausal women.MRI 脑实质增强、绝经后妇女的乳房密度和血清激素。
Int J Cancer. 2018 Aug 15;143(4):823-830. doi: 10.1002/ijc.31370. Epub 2018 Mar 25.
6
Mammographic Density Change With Estrogen and Progestin Therapy and Breast Cancer Risk.雌激素和孕激素治疗引起的乳房X线密度变化与乳腺癌风险
J Natl Cancer Inst. 2017 Sep 1;109(9). doi: 10.1093/jnci/djx001.
7
Endometriosis and mammographic density measurements in the Nurses' Health Study II.护士健康研究II中的子宫内膜异位症与乳房X线密度测量
Cancer Causes Control. 2016 Oct;27(10):1229-37. doi: 10.1007/s10552-016-0801-y. Epub 2016 Aug 22.
8
Mammographic density and breast cancer risk in White and African American Women.白人女性和非裔美国女性的乳腺密度与乳腺癌风险。
Breast Cancer Res Treat. 2012 Sep;135(2):571-80. doi: 10.1007/s10549-012-2185-3. Epub 2012 Aug 3.
9
Quantification of breast density with spectral mammography based on a scanned multi-slit photon-counting detector: a feasibility study.基于扫描多狭缝光子计数探测器的光谱乳腺密度定量:一项可行性研究。
Phys Med Biol. 2012 Aug 7;57(15):4719-38. doi: 10.1088/0031-9155/57/15/4719. Epub 2012 Jul 6.
10
No evidence for association of inherited variation in genes involved in mitosis and percent mammographic density.未发现有丝分裂相关基因遗传变异与乳腺 X 线密度百分比之间存在关联。
Breast Cancer Res. 2012 Jan 7;14(1):R7. doi: 10.1186/bcr3088.